Smoking, use of moist snuff, and risk of chronic inflammatory diseases

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 11, 2010, Pages 1217-1222

  Carlens, Cecilia ^a   Hergens, Maria Pia ^b   Grunewald, Johan ^a   Ekbom, Anders ^a   Eklund, Anders ^a   Höglund, Caroline Olgart ^a,b   Askling, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cohort; Inflammatory bowel disease; Rheumatoid arthritis; Sarcoidosis; Tobacco smoking

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CHRONIC INFLAMMATION; COHORT ANALYSIS; CROHN DISEASE; FEMALE; HUMAN; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; RISK REDUCTION; SMOKELESS TOBACCO; SMOKING; SWEDEN; ULCERATIVE COLITIS; FOLLOW UP; REGISTER; RISK ASSESSMENT; SARCOIDOSIS;

ADULT; ARTHRITIS, RHEUMATOID; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIPLE SCLEROSIS; REGISTRIES; RISK ASSESSMENT; SARCOIDOSIS; SMOKING; SWEDEN; TOBACCO, SMOKELESS;

EID: 77954717701     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200909-1338OC     Document Type: Article

References (52)

1. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, Alfredsson L. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-841.
2. Criswell LA, Merlino LA, Cerhan JR, Mikuls TR, Mudano AS, Burma M, Folsom AR, Saag KG. Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. Am J Med 2002;112:465-471. (Pubitemid 34450707)
3. Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006:119:503e1-503e9.
4. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006;81: 1462-1471. (Pubitemid 44687433)
5. Hernan MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 2001;154:69-74.
6. Hawkes CH. Smoking is a risk factor for multiple sclerosis: a metaanalysis. Mult Scler 2007;13:610-615.
7. Sundstrom P, Nystrom L, Hallmans G. Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 2008;15:579-583.
8. Riise T, Nortvedt MW, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology 2003;61:1122-1124.
9. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982;284:706.
10. Lindberg E, Tysk C, Andersson K, Jarnerot G. Smoking and inflammatory bowel disease: a case control study. Gut 1988;29:352-357.
11. Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, Wallander MA. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 2005;22:309-315.
12. Hance AJ, Basset F, Saumon G, Danel C, Valeyre D, Battesti JP, Chretien J, Georges R. Smoking and interstitial lung disease: the effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 1986;465:643-656.
13. Musellim B, Kumbasar OO, Ongen G, Cetinkaya E, Turker H, Uzaslan E, Yenturk E, Uzun O, Saglam L, Celik G, et al. Epidemiological features of Turkish patients with sarcoidosis. Respir Med 2009;103: 907-912.
14. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, Terrin ML, Weinberger SE, Moller DR, McLennan G, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004;170:1324-1330.
15. Valeyre D, Soler P, Clerici C, Pre J, Battesti JP, Georges R, Hance AJ. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988;43:516-524.
16. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372-377.
17. Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine - a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol 2005;2:536-544.
18. Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 2005;4:673-684.
19. Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67:1488-1492.
20. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
21. Bostrom G. Chapter 9: habits of life and health. Scand J Public Health Suppl 2006;67:199-228.
22. Holm H, Jarvis MJ, Russell MA, Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl) 1992;108:507-511.
23. Persson PG, Hellers G, Ahlbom A. Use of oral moist snuff and inflammatory bowel disease. Int J Epidemiol 1993;22:1101-1103.
24. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009;73:696-701.
25. Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med 2007;262:351-359.
26. Shoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-241.
27. Scott DA, Martin M. Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases. World J Gastroenterol 2006;12:7451-7459.
28. Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, Kumagai S. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2009;69:70-81.
29. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009; 373:659-672.
30. Harel-Meir M, Sherer Y, Shoenfeld Y. Tobacco smoking and autoimmune rheumatic diseases. Nat Clin Pract Rheumatol 2007;3:707-715. (Pubitemid 350187016)
31. Stolt P, Kallberg H, Lundberg I, Sjogren B, Klareskog L, Alfredsson L. Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA Study. Ann Rheum Dis 2005;64:582-586. (Pubitemid 40469088)
32. McGrath J, McDonald JW, Macdonald JK. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2004;4:CD004722.
33. Karban A, Eliakim R. Effect of smoking on inflammatory bowel disease: is it disease or organ specific? World J Gastroenterol 2007;13:2150-2152.
34. Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 2007;13:6134-6139.
35. McGilligan VE, Wallace JM, Heavey PM, Ridley DL, Rowland IR. Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. Inflamm Bowel Dis 2007;13:108-115.
36. Blanchet MR, Israel-Assayag E, Cormier Y. Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am J Respir Crit Care Med 2004;169:903-909.
37. Maier LA. Is smoking beneficial for granulomatous lung diseases? Am J Respir Crit Care Med 2004;169:893-895.
38. Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain 2005;128:1461-1465.
39. Sundstrom P, Nystrom L. Smoking worsens the prognosis in multiple sclerosis. Mult Scler 2008;14:1031-1035.
40. Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res 2004;1027:48-58.
41. Chen JL, Wei L, Bereczki D, Hans FJ, Otsuka T, Acuff V, Ghersi-Egea JF, Patlak C, Fenstermacher JD. Nicotine raises the influx of permeable solutes across the rat blood-brain barrier with little or no capillary recruitment. J Cereb Blood Flow Metab 1995;15:687-698.
42. Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstrom C, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692-701.
43. Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991;100:350-358.
44. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994: a registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:46-52.
45. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis: a 15-year European study. Am Rev Respir Dis 1984;130:29-32.
46. Lapidus A. Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol 2006;12:75-81.
47. Lapidus A, Bernell O, Hellers G, Persson PG, Lofberg R. Incidence of Crohn's disease in Stockholm County 1955-1989. Gut 1997;41:480-486.
48. Soderlin MK, Borjesson O, Kautiainen H, Skogh T, Leirisalo-Repo M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 2002;61:911-915.
49. Stewenius J, Adnerhill I, Ekelund G, Floren CH, Fork FT, Janzon L, Lindstrom C, Mars I, Nyman M, Rosengren JE. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden: a 25-year incidence study. Scand J Gastroenterol 1995;30:38-43.
50. Sundstrom P, Nystrom L, Forsgren L. Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden. J Neurol Neurosurg Psychiatry 2003;74:29-32.
51. Svenningsson A, Runmarker B, Lycke J, Andersen O. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand 1990;82:161-168.
52. Lee PN, Hamling J. Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med 2009;7:36.